1 deck published between 2019-07-01 and 2019-07-01 — 29 pages, 29 analysed slides total.
Each deck in chronological order — click to open. This is the story of the campaign as it unfolded.
CareDx is a $1.7bn story built on AllSure, a cfDNA kidney-rejection test that misses 40% of rejections and faces 70% annual patient attrition, competition and Medicare reset — ~70% downside.